HOME >> BIOLOGY >> NEWS
UCSF Researchers Identify Key Genes In Bone Healing Process That Could Lead To New, Molecular-Based Treatments

Anaheim, Calif. -- Researchers from the University of California San Francisco studying bone healing in animal models have found that two genes essential for bone formation in the fetus are also key to successful fracture repair in the adult.

Through a clever biologic regulatory process, the two genes become inactive when fetal development concludes but then resurface when needed to help mend broken bones.

"These findings shed new light on the bone formation process at the molecular level. Now we can use these principles to begin to develop new clinical treatments for troublesome fractures in which we mimic the natural healing process," said Theodore Miclau, MD, lead investigator and UCSF assistant professor of orthopaedic surgery who treats patients at San Francisco General Hospital Medical Center.

Miclau presented the study findings here today (February 5) at the annual meeting of the American Academy of Orthopaedic Surgeons. Working with adult mice, the UCSF team focused on the expression patterns of two embryonic genes, cbfal and Indian hedgehog, which are known to be indispensable in fetal bone formation.

Study results showed the genes reappeared in the bone of a mature animal when it underwent a fracture. During this process of "reinduction," the genes activated the expression of two proteins that contributed to bone healing in the adult model in a sequence very similar to the pattern that takes place during skeletal formation in the fetus.

The researchers analyzed bone tissue at the fracture site in adult mice at 3, 6, 8, 10, and 14 days after fracture to assess the presence of growth factors and other proteins. The UCSF team is believed to be the first to report the expression of the two genes in an animal bone repair model.

"Understanding this cascade of events and the specific growth factors involved in bone repair is a small step but a significant one. If we can replicate the pattern and target therapy directly to t
'"/>

Contact: Corinna Kaarlela
corinna@itsa.ucsf.edu
415-476-3804
University of California - San Francisco
5-Feb-1999


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
(Date:5/21/2013)... University researchers have developed a new method for ... holes in the cell surface. The technique could ... related biological fields. , Bulk electroporation a ... reversible nanopores in the cell membrane that are ... is an increasingly popular method of cell transfection. ...
(Date:5/21/2013)... new University of Michigan Water Center today awarded ... Great Lakes restoration and protection efforts. , The ... diverse projects, including efforts to track the remediation ... techniques to control non-native weedy plant invasions; study ... fish responses to restoration activities. , The grants ...
(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...
Breaking Biology News(10 mins):Single-cell transfection tool enables added control for biological studies 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4Do men's and women's hearts burn fuel differently? 2
(Date:5/22/2013)... , May 22, 2013  Cleveland BioLabs, Inc. (NASDAQ: CBLI) ... the Second Annual Marcum LLP Microcap Conference, May 30, in ... Neil Lyons , CPA, Chief Financial Officer ... programs on May 30 at 1:30 p.m. Eastern Time.  A ... available on the Investors page of the Cleveland BioLabs website ...
(Date:5/22/2013)... Express Diagnostics Int’l, Inc. (EDI) ... are pleased to announce a sponsorship agreement with Erebus ... Zealand distributor of DrugCheck® onsite testing devices, manufactured by ... the Austin 400 May 17-19 in Austin, Texas. , ... involves each car of the Erebus Motorsport team displaying ...
(Date:5/22/2013)... Miami, FL (PRWEB) May 22, 2013 A ... effects of probiotics on athletes to find that those who ... percent longer. The results from the study showed that in ... Probiotic Action, known for their adult acne treatment ... acne, and how it may help their skin condition. ...
(Date:5/21/2013)... , May 22, 2013 First ... formulation of glycopyrronium bromide designed using Prosonix, particle engineering ... developing a portfolio of inhaled Respiratory Medicines by ... with PSX1002 that will assess its effect on lung ... in patients with moderate to severe chronic obstructive pulmonary ...
Breaking Biology Technology:Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4
Cached News: